YSB Inc.
9885.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.34B
Close$
Share Statistics
| Market cap | $2.34 Billion |
|---|---|
| Enterprise Value | $2.75 Billion |
| Dividend Yield | $0.13 (3.65%) |
| Earnings per Share | $0.22 |
| Beta | 0.47 |
| Outstanding Shares | 676,038,481 |
Return
| Return on Equity | 11.35% |
|---|---|
| Return on Assets | 3.66% |
| Return on Invested Capital | 3.40% |
Valuation & Multiples
| P/E Ratio | 10.78 |
|---|---|
| PEG | 27.01 |
| Price to Sales | 0.06 |
| Price to Book Ratio | 1.14 |
| Enterprise Value to Revenue | 0.07 |
| Enterprise Value to EBIT | 32.05 |
| Enterprise Value to Net Income | 10 |
| Total Debt to Enterprise | 0.9 |
| Debt to Equity | 1.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 20, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
March 15, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About YSB Inc.
6,950 employees
CEO: Buzhen Zhang YSB Inc. provides a comprehensive digital platform tailored for the Chinese pharmaceutical sector, supporting a wide array of stakeholders such as drug companies, distributors, vendors, pharmacies, and primary healthcare facilities. Its ...